v3 Template
T
Trethera Corporation
Biopharmaceutical
Los Angeles, USA
Founded
--
Employees
--
Total Funding
$15.0M
Funding Rounds
8
Last Funding
2025-12-16
About Trethera Corporation
Trethera is a clinical stage biopharmaceutical company focused on developing novel drugs targeting nucleotide metabolism for the treatment of cancer and autoimmune diseases. Their mission is to create transformative, first-in-class therapies with a patient-centered approach.
Products & Services
TRE-515:A first-in-class dCK inhibitor, a groundbreaking daily pill designed to fight cancer and autoimmune diseases by targeting diseases at their root, offering a potentially safer and more effective solution with fewer side effects.
Specialties
Nucleotide Metabolism
Cancer Therapies
Autoimmune Disease Treatments
Drug Development
Funding History
Debug: View Raw Funding Data
| # | Type | Amount Fields | Date Fields | Investors |
|---|---|---|---|---|
| 1 |
RT: Grant T: - FT: Grant |
A: 2700000 MR: - FA: $2.7 million FAN: 2700000 |
D: 2025-12-16 FD: 2025-12-16 |
1 investors |
| 2 |
RT: Grant T: - FT: Grant |
A: 1800000 MR: - FA: $1.8 million FAN: 1800000 |
D: 2025-09-23 FD: 2025-09-23 |
1 investors |
| 3 |
RT: SBIR Grant T: - FT: SBIR Grant |
A: 2300000 MR: - FA: $2.3 million FAN: 2300000 |
D: 2025-08-26 FD: 2025-08-26 |
1 investors |
| 4 |
RT: SBIR Grant T: - FT: SBIR Grant |
A: 3000000 MR: - FA: 3 million FAN: 3000000 |
D: 2025-08-19 FD: 2025-08-19 |
1 investors |
| 5 |
RT: Grant T: - FT: Grant |
A: 2000000 MR: - FA: $2 million FAN: 2000000 |
D: 2024-07-16 FD: 2024-07-16 |
1 investors |
| 6 |
RT: Grant T: - FT: Grant |
A: 600000 MR: - FA: $600,000 FAN: 600000 |
D: 2023-08-14 FD: 2023-08-14 |
1 investors |
| 7 |
RT: Grant T: - FT: Grant |
A: 600000 MR: - FA: $0.6M FAN: 600000 |
D: 2023-06-27 FD: 2023-06-27 |
1 investors |
| 8 |
RT: Grant T: - FT: Grant |
A: 2000000 MR: - FA: 2 million FAN: 2000000 |
D: 2023-05-30 FD: 2023-05-30 |
1 investors |
Grant
Latest
2025-12-16
$2.7M
1 investor (Pro only)
Grant
2025-09-23
$1.8M
SBIR Grant
2025-08-26
$2.3M
Growth Metrics
+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active
Mock Up
Team & Leadership
No team data available
Team information is not yet available for this company
Recent News
Trethera Corporation Announces New Product Launch
2 days agoCompany unveils innovative solution to transform the industry, expanding market reach and capabilities...
Read more →Leadership Team Expands with Industry Veteran
1 week agoNew executive brings 20+ years of experience to accelerate growth and strategic initiatives...
Read more →Company Recognized as Industry Leader
2 weeks agoReceives prestigious award for innovation and customer satisfaction in competitive market...
Read more →Mock Up
Key Competitors
C1
Competitor Alpha
Series B · $50M raised
C2
Competitor Beta
Series C · $120M raised
C3
Competitor Gamma
Series A · $25M raised
C4
Competitor Delta
Seed · $10M raised
Mock Up
Company Details
- Website
- trethera.com
- Industries
- Biopharmaceutical
- Locations
-
Los Angeles, USA
Los Angeles
Similar Companies
Discover AI-powered company recommendations based on industry, funding, and team profiles.
Upgrade to ProTechnology Stack
Discover the backend, frontend, and infrastructure technologies powering this company's products.
Upgrade to Pro